<DOC>
	<DOCNO>NCT02925351</DOCNO>
	<brief_summary>This pilot trial study well fluorine F 18 clofarabine positron emission tomography ( PET ) /computed tomography ( CT ) work image patient autoimmune inflammatory disease . Fluorine F 18 clofarabine imaging agent tracer may take inflammatory tissue body . Diagnostic imaging , PET/CT scan , use measure amount inject tracer take inflammatory tissue . PET/CT scan may help determine fluorine F 18 clofarabine distribute throughout body .</brief_summary>
	<brief_title>Fluorine F 18 Clofarabine PET/CT Imaging Patients With Autoimmune Inflammatory Diseases</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Determine fluorine F 18 clofarabine ( 18F‐clofarabine ) distribute body , patient autoimmune inflammatory disease . II . Determine whether 18F‐clofarabine used image patient autoimmune inflammatory disease . OUTLINE : Patients receive fluorine F 18 clofarabine intravenously ( IV ) undergo single PET/CT scan 120 minute .</detailed_description>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Arteritis</mesh_term>
	<mesh_term>Takayasu Arteritis</mesh_term>
	<mesh_term>Aortic Arch Syndromes</mesh_term>
	<mesh_term>Clofarabine</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>Must 18 year old . Diagnosed autoimmune inflammatory disorder . Exclusion Criteria Women childbearing age undergo pregnancy test provide free charge . Patients unable undergo comply PET/CT scan due preexist medical condition include claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>